SRRM2 and Alzheimer disease: Notably, it is reported that RNA-binding protein TIA-1 could drive and potentiate TAU LLPS, thus promoting the generation of toxic oligomeric TAU in the brains of AD patients [72], which indicates that TIA-1 might be a potential target for AD.